CVE-2008-6831

Description

Multiple cross-site scripting (XSS) vulnerabilities in Atlassian JIRA Enterprise Edition 3.13 allow remote attackers to inject arbitrary web script or HTML via the (1) fullname (Full Name) parameter in the ViewProfile page or (2) returnUrl parameter in a form, as demonstrated using secure/AddComment!default.jspa (aka "Add Comment").

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.48%
Vendor Advisory atlassian.com Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://osvdb.org/49415 vdb entry
http://confluence.atlassian.com/display/JIRA/JIRA+Security+Advisory+2008-10-29 patch vendor advisory
http://www.securityfocus.com/bid/31967 vdb entry
http://osvdb.org/49416 vdb entry
https://exchange.xforce.ibmcloud.com/vulnerabilities/46168 vdb entry
http://secunia.com/advisories/32113 third party advisory vendor advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/46167 vdb entry

Frequently Asked Questions

What is the severity of CVE-2008-6831?
CVE-2008-6831 has been scored as a medium severity vulnerability.
How to fix CVE-2008-6831?
To fix CVE-2008-6831, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2008-6831 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2008-6831 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.